Research & Development

Our expertise

Supported by our scientific and technical expertise, we provide services to meet clinical needs for personalized medicine. At the crossroads between industry and research, our team shows a unique savoir-faire.

Our solutions are based on a clever mix of:

Molecular biology

Cellular biology

Radiobiology

Biological samples

Translational research

Industrial development

Our
R&D
Research & Dévelopment Unit

Innovation is at the heart of our DNA

The mission of our R&D unit is to innovate, develop and create new tests in order to propose new solutions adapted to each patient. We collaborate with research laboratories, in particular the INSERM UMR 1296 academic laboratory “Radiation: defense, health, environment”, directed by Dr Nicolas Foray, in Lyon, to carry out our developments.

Our R&D unit focuses on:

Our patented technology

Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity.

CANCERS (BASEL). 2021 MAY 19;13(10):2477. DOI: 10.3390/CANCERS13102477. PMID: 34069662; PMCID: PMC8160794. Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S

Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity.

CANCERS (BASEL). 2021 MAY 19;13(10):2477. DOI: 10.3390/CANCERS13102477. PMID: 34069662; PMCID: PMC8160794. Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S

Would you like to join our team? We recruit regularly, send us your application! Join our group, a specialist in radiation risk management.

We use cookies to guarantee you the best experience on our website. By continuing to use this site you agree to this use. See our privacy policy.